Correlation Between MediciNova and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both MediciNova and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Cue Biopharma, you can compare the effects of market volatilities on MediciNova and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Cue Biopharma.
Diversification Opportunities for MediciNova and Cue Biopharma
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between MediciNova and Cue is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of MediciNova i.e., MediciNova and Cue Biopharma go up and down completely randomly.
Pair Corralation between MediciNova and Cue Biopharma
Given the investment horizon of 90 days MediciNova is expected to generate 1.49 times more return on investment than Cue Biopharma. However, MediciNova is 1.49 times more volatile than Cue Biopharma. It trades about 0.13 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.13 per unit of risk. If you would invest 168.00 in MediciNova on September 1, 2024 and sell it today you would earn a total of 39.00 from holding MediciNova or generate 23.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MediciNova vs. Cue Biopharma
Performance |
| Timeline |
| MediciNova |
| Cue Biopharma |
MediciNova and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MediciNova and Cue Biopharma
The main advantage of trading using opposite MediciNova and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| MediciNova vs. Tff Pharmaceuticals | MediciNova vs. Eliem Therapeutics | MediciNova vs. Inhibrx | MediciNova vs. Enliven Therapeutics |
| Cue Biopharma vs. Tff Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics | Cue Biopharma vs. Inhibrx | Cue Biopharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |